Background: Non-vitamin K antagonist oral anticoagulants including rivaroxaban are widely
used for stroke prevention in patients with atrial fibrillation (AF). We investigated the …

In recent years a growing body of evidence supported the role of inflammation in the
initiation, maintenance and outcome of atrial fibrillation (AF). Nevertheless, despite a large …

Background Atrial fibrillation (AF) is associated with a high risk of stroke. The contribution of
arrhythmia to events is clear in sustained forms of AF, but in paroxysmal AF, presently …

Background Patients with atrial fibrillation are at increased risk of stroke and mortality. It is
not clear if inflammatory biomarkers are associated with stroke and mortality in patients with …

Background Inflammation has been associated with cardiovascular disease and the burden
of atrial fibrillation (AF). In this study we evaluate inflammatory biomarkers and future …

Objective Atrial fibrillation (AF) is a risk factor for stroke and mortality and the prothrombotic
state has been linked to inflammation. In this study we evaluated the relationship between …

Objective The neutrophil-to-lymphocyte ratio (NLR) is an inflammation marker that can be
used to detect atrial inflammatory changes, which may contribute to a reduced left atrial (LA) …

With great interest, I read the recent paper published in your journal entitled “Comparison of
the Relationship Between Inflammatory Markers and Atrial Fibrillation Burden.” 1 Atrial …

BACKGROUND: The association between inflammatory status and thrombosis in patients
with atrial fibrillation (AF) is unclear. We studied the correlation between inflammation and …

Atrial fibrillation (AF) is the most common sustained rhythm disturbance resulting in
substantial morbidity and mortality as well as increased medical costs in general population …